Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Ventana Medical Systems

This article was originally published in The Gray Sheet

Executive Summary

Ventana Medical Systems: Instrument and reagent manufacturer files registration statement with SEC for a secondary offering of 2.9 mil. shares, including 1.9 mil. to be sold by the company and 1 mil. by selling shareholders. Net proceeds from the offering will go toward "general corporate purposes, which may include expansion of sales and marketing activities, research and development, clinical trials, capital expenditures, repayment of indebtedness and working capital." Dillon, Read & Co. will serve as lead managers for the offering; Bear, Stearns and Cowen & Company are co-managers. Underwriters have an over-allotment option covering 427,500 additional shares, which would be sold by shareholders...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007445

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel